Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder

NCT01691066 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01691066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01691066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2012
Completion date
February 27, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders